EBioMedicine
| Discipline | Medicine |
|---|---|
| Language | English |
| Publication details | |
| History | 2014-present |
| Publisher | |
| Frequency | Continuous |
| Yes | |
| 10.205 (2021) | |
| Standard abbreviations | |
| ISO 4 | EBioMedicine |
| Indexing | |
| ISSN | 2352-3964 |
| Links | |
eBioMedicine is a peer-reviewed open access medical journal initially launched by Elsevier, shortly thereafter supported by Cell Press and The Lancet, and in 2018 incorporated in The Lancet family journals, at the occasion of the inception of its sister journal eClinicalMedicine (Impact Factor 17.033), also published by The Lancet.[1] In January 2022 eBioMedicine and eClinicalMedicine became parts of THE LANCET Discovery Science, a suite of open access journals dedicated to essential early evidence. https://www.thelancet.com/discovery-science
The journal is abstracted and indexed in Index Medicus/MEDLINE/PubMed.[2]
References
- ^ "EBioMedicine publishes basic biomedical to clinical research". EBioMedicine.
- ^ "EBioMedicine". NLM Catalog. National Center for Biotechnology Information. Retrieved 2016-05-20.
External links
  | This article about a general medical journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |